Evidence map›Paper›PMID 29373532›Full record

ReviewFoods (Basel, Switzerland)2018

The Role of Bacteria, Probiotics and Diet in Irritable Bowel Syndrome.

Ashton Harper, Malwina M Naghibi, Davinder Garcha

Open access · goldAbstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
8.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 74 citations in OpenAlex.

  1. Nutrients · 2019
    Trial
  2. Effects ofNutrients · 2019
    Trial
  3. Review
  4. The Effects of Fermented Rice Drink WithJournal of neurogastroenterology and motility · 2024
    Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Influence of the MicroalgaFoods (Basel, Switzerland) · 2020
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Ashton HarperProtexin, Medical Affairs, Probiotics International Ltd., Lopen Head, Somerset TA13 5JH, UK. ashton.harper@protexin.com.
Malwina M NaghibiProtexin, Medical Affairs, Probiotics International Ltd., Lopen Head, Somerset TA13 5JH, UK. malwina.naghibi@protexin.com.
Davinder GarchaProtexin, Medical Affairs, Probiotics International Ltd., Lopen Head, Somerset TA13 5JH, UK. davinder.garcha@protexin.com.
Protexin · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Irritable bowel syndrome is a highly prevalent gastrointestinal disorder that threatens the quality of life of millions and poses a substantial financial burden on healthcare systems around the world. Intense research into the human microbiome has led to fascinating discoveries which directly and indirectly implicate the diversity and function of this occult organ in irritable bowel syndrome (IBS) pathophysiology. The benefit of manipulating the gastrointestinal microbiota with diet and probiotics to improve symptoms has been demonstrated in a wealth of both animal and human studies. The positive and negative mechanistic roles bacteria play in IBS will be explored and practical probiotic and dietary choices offered.

Indexed as

irritable bowel syndrome (IBS)microbiotaprobiotics

Identifiers

PMID29373532
PMCPMC5848117
OpenAlexW2790930627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.